1 / 4

P-4E-BP1/4E-BP1

Supplementary Figure 1. A. P-4E-BP1/4E-BP1. P-p70 S6K/p70 S6K. P- Akt / Akt. Relative levels. ND. B. C. c leaved PARP/PARP. LC3II/LC3I. Relative levels. Relative levels. Supplementary Figure 2. Jurkat. SNT13. KHYG1. KAI3. A. *. *. *. *. *. Cell number (x10 5 ). *. *. *.

khan
Télécharger la présentation

P-4E-BP1/4E-BP1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1 A P-4E-BP1/4E-BP1 P-p70 S6K/p70 S6K P-Akt/Akt Relative levels ND B C cleaved PARP/PARP LC3II/LC3I Relative levels Relative levels

  2. Supplementary Figure 2 Jurkat SNT13 KHYG1 KAI3 A * * * * * Cell number (x105) * * * * * * * hours hours hours hours B C * * * * * * * * * Viability (% of control) * * MTS reduction (% of control) * Days Rapamycin (nM)

  3. Supplementary Figure 3 B SNT16 - + SNK6 - + A CCI-779 P-4E-BP1 P-p70S6K p27 CDK2 Rb β-Actin C * * * * %of total %of total * * * *

  4. Supplementary Figure 4 * * * * * * Tumor volume (mm3) * CCI-779 * * * * * * Days

More Related